Pharmacologic Therapy for Non ST-segment Elevation Acute Coronary Syndromes: Focus on Antithrombotic Therapy

Author： Danchin Nicolas   Aïssaoui Nadia  

Publisher： Springer Publishing Company

ISSN： 0920-3206

Source： Cardiovascular Drugs and Therapy, Vol.24, Iss.4, 2010-08, pp. : 325-330

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antithrombotic Therapy in Non-ST-Segment Elevation Acute Coronary Syndromes: Recommendations of the Rio de la Plata Expert Panel

By  

Clinical Drug Investigation, Vol. 19, Iss. 6, 2000-06 ,pp. : 409-420

Adis International

Access to resources Recommend Favorite

Antithrombotic therapy in ST-segment elevation myocardial infarction

By Wong Cheuk-Kit   White Harvey D  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 2, 2011-02 ,pp. : 213-223

Informa Healthcare

Access to resources Recommend Favorite

Glycoprotein IIb/IIIa Receptor Therapy in Percutaneous Coronary Intervention and Non-ST-Segment Elevation Acute Coronary Syndromes: Estimating the Economic Implications

By Hillegass W.B.  

PharmacoEconomics, Vol. 19, Iss. 1, 2001-01 ,pp. : 41-55

Adis International

Access to resources Recommend Favorite

Clinical use of enoxaparin in the management of non-ST segment elevation acute coronary syndromes

By Galla John M   Mahaffey Kenneth W  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 7, 2005-06 ,pp. : 1241-1251

Informa Healthcare

Access to resources Recommend Favorite

Paclitaxel: Acute coronary syndrome with ST-segment elevation: case report

By  

Reactions Weekly, Vol. 1, Iss. 1268, 2009-01 ,pp. : 23-24

Adis International

Access to resources Recommend Favorite